☆ 4.6 Editorial Material

Eculizumab as a therapeutic approach for severe crescentic recurrence of immunoglobulin A nephropathy after kidney transplantation

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Related references

Note: Only part of the references are listed.
Article Genetics & Heredity

Case Report: A Rare Truncating Variant of the CFHR5 Gene in IgA Nephropathy

Gabriella Guzzo et al.

Summary: IgA nephropathy is the most common primary glomerulonephritis globally, with some patients showing complement deposits similar to aHUS. Genetic variations may affect the progression and treatment outcomes of IgAN.

FRONTIERS IN GENETICS (2021)

Add to Collection
Review Immunology

Complement dysregulation in glomerulonephritis

Kati Kaartinen et al.

SEMINARS IN IMMUNOLOGY (2019)

Add to Collection
Article Urology & Nephrology

Atypical Hemolytic Uremic Syndrome Associated with Complement Factor H Mutation and IgA Nephropathy: A Case Report Successfully Treated with Eculizumab

Hironori Nakamura et al.

NEPHRON (2018)

Add to Collection
Article Immunology

First Treatment of Relapsing Rapidly Progressive IgA Nephropathy With Eculizumab After Living Kidney Donation: A Case Report

A. L. Herzog et al.

TRANSPLANTATION PROCEEDINGS (2017)

Add to Collection
Article Urology & Nephrology

Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum?

Troels Ring et al.

CLINICAL KIDNEY JOURNAL (2015)

Add to Collection
Article Pediatrics

Eculizumab treatment for rescue of renal function in IgA nephropathy

Therese Rosenblad et al.

PEDIATRIC NEPHROLOGY (2014)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.